Please login to the form below

Not currently logged in


This page shows the latest BI news and features for those working in and with pharma, biotech and healthcare.

BMS pays Zenas $50m upfront for regional rights to autoimmune disease antibody

BMS pays Zenas $50m upfront for regional rights to autoimmune disease antibody

Bristol Myers Squibb (BMS) and Zenas BioPharma have entered into a strategic license and collaboration agreement to develop and commercialise a novel, bi-functional antibody called obexelimab for autoimmune diseases. ... Obexelimab is an investigational

Latest news

More from news
Approximately 4 fully matching, plus 111 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.

Subscribe to our email news alerts


Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....